Skip to main content
. 2008 Oct 17;3(10):e3421. doi: 10.1371/journal.pone.0003421

Table 2. PARK2 gene variants in PD cases and controls.

Gene Heterozygous variants Parkinson's disease Control group
N (%) N (%)
PARK2 p.E16E; c.G48T 3 (5.3) 1 (2.0)
p.P37P; c.G111A 8 (14.0) 6 (11.8)
p.A46T; c.G136A 1 (1.8) 0
p.P153R; c.C458G 0 1 (2.0)
p.S167N; c.G500A 4 (7.0) 4 (7.8)
p.M192L; c.A574G 7 (12.3) 6 (11.8)
p.L261L; c.A783G 13 (22.8) 14 (27.4)
p.G319G; c.T957C 5 (8.8) 4 (7.8)
p.R334H; c.G1001A 1 (1.8) 0
p.V380L; c.G1138A 2 (3.5) 3 (5.9)
Homozygous variants
p.P37P; c.G111A 1 (1.8) 3 (5.9)
p.S167N; c.G500A 1 (1.8) 0
p.L261L; c.A783G 1 (1.8) 3 (5.9)
p.V380L; c.G1138A 1 (1.8) 1 (2.0)